Decline of exhaled isoprene in lung cancer patients correlates with immune activation

Journal of Breath Research

Volumn 6, Issue 2, 2012, Pages

  Fuchs, D ^a   Jamnig, H ^b   Heininger, P ^b   Klieber, M ^a   Schroecksnadel, S ^a   Fiegl, M ^c   Hackl, M ^b   Denz, H ^b   Amann, A ^a,d  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b Hospital Natters   (Austria)

^c INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^d ERICH SCHMID INSTITUTE OF MATERIALS SCIENCE   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ISOPRENE; KYNURENINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NEOPTERIN; TRIACYLGLYCEROL; TRYPTOPHAN; 1,3 BUTADIENE DERIVATIVE; HEMITERPENE; PENTANE; TUMOR MARKER;

ADULT; AGED; ARTICLE; BREATH ANALYSIS; CANCER GRADING; CANCER PATIENT; CANCER STAGING; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYMOLOGY; EXHALATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNE STATUS; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; COMPARATIVE STUDY; DISEASE COURSE; IMMUNITY; IMMUNOLOGY; LUNG TUMOR; METABOLISM; METHODOLOGY; MIDDLE AGED; PHYSIOLOGY; PLANT;

BREATH TESTS; BUTADIENES; DISEASE PROGRESSION; EXHALATION; FEMALE; HEMITERPENES; HUMANS; IMMUNITY; LUNG NEOPLASMS; MALE; MIDDLE AGED; PENTANES; PLANTS; TUMOR MARKERS, BIOLOGICAL;

EID: 84858776419     PISSN: 17527155     EISSN: 17527163     Source Type: Journal    
DOI: 10.1088/1752-7155/6/2/027101     Document Type: Article

References (48)

1. McCulloch M, Jezierski T, Broffman M, Hubbard A, Turner K and Janecki T 2006 Diagnostic accuracy of canine scent detection in early- and late-stage lung and breast cancers Integr. Cancer Ther. 5 30-9 (Pubitemid 43260792)
2. Stone B G, Besse T J, Duane W C, Evans C D and DeMaster E G 1993 Effect of regulating cholesterol biosynthesis on breath isoprene excretion in men Lipids 28 705-8 (Pubitemid 23241435)
3. Rieder J, Lirk P, Ebenbichler C, Gruber G, Prazeller P, Lindinger W and Amann A 2001 Analysis of volatile organic compounds: possible applications in metabolic disorders and cancer screening Wien. Klin. Wochenschr. 113 181-5 (Pubitemid 32244768)
4. Di Natale C, Macagnano A, Martinelli E, Paolesse R, D'Arcangelo G, Roscioni C, Finazzi-Agro A and D'Amico A 2003 Lung cancer identification by the analysis of breath by means of an array of nonselective gas sensors Biosens. Bioelectron. 18 1209-18 (Pubitemid 36776581)
5. Chan H P, Lewis C and Thomas P S 2009 Exhaled breath analysis: novel approach for early detection of lung cancer Lung Cancer 63 164-8
6. King J, Koc H, Unterkofler K, Mochalski P, Kupferthaler A, Teschl G, Teschl S, Hinterhuber H and Amann A 2010 Physiological modeling of isoprene dynamics in exhaled breath J. Theor. Biol. 267 626-37
7. Salerno-Kennedy R and Cashman K D 2005 Potential applications of breath isoprene as a biomarker in modern medicine: a concise overview Wien. Klin. Wochenschr. 117 180-6 (Pubitemid 40645909)
8. Bajtarevic A et al 2009 Noninvasive detection of lung cancer by analysis of exhaled breath BMC Cancer 9 348
9. O'Gorman P, McMillan D C and McArdle C S 2000 Prognostic factors in advanced gastrointestinal cancer patients with weight loss Nutr. Cancer 37 36-40 (Pubitemid 30650664)
10. Forrest L M, McMillan D C, McArdle C S, Angerson W J and Dunlop D J 2003 Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer Br. J. Cancer 89 1028-30 (Pubitemid 37239206)
11. Maltoni M et al 2005 Prognostic factors in advanced cancer patients: evidence-based clinical recommendations - a study by the Steering Committee of the European Association for palliative care J. Clin. Oncol. 23 6240-8
12. Kronberger P, Weiss G, Tschmelitsch J, Fuchs D, Salzer G M, Wachter H and Reibnegger G 1995 Predictive value of urinary neopterin in patients with lung cancer Eur. J. Clin. Chem. Clin. Biochem. 33 831-7
13. Prommegger R, Widner B, Murr C, Unger A, Fuchs D and Salzer G M 2000 Neopterin: a prognostic variable in operations for lung cancer Ann. Thorac. Surg. 70 1861-4 (Pubitemid 32015274)
14. Mohamed K H, Mobasher A A, Yousef A R, Salah A, El-Naggar I Z, Ghoneim A H and Light R W 2001 BAL neopterin: a novel marker for cell-mediated immunity in patients with pulmonary tuberculosis and lung cancer Chest 119 776-80 (Pubitemid 32197647)
15. Sucher R, Schroecksnadel K, Weiss G, Margreiter R, Fuchs D and Brandacher G 2010 Neopterin, a prognostic marker in human malignancies Cancer Lett. 287 13-22
16. Brandacher G et al 2006 Prognostic value of indoleamine 2,3-dioxygenase expression in colorectal cancer: impact on tumor-infiltrating T-cells Clin. Cancer Res. 12 1144-51 (Pubitemid 43342502)
17. Brandacher G, Schroecksnadel K, Winkler C, Margreiter R and Fuchs D 2006 Antitumoral activity of interferon-γinvolved in impaired immune function in cancer patients Curr. Drug Metab. 7 599-612 (Pubitemid 44226588)
18. Weinlich G, Murr C, Richardsen L, Winkler C and Fuchs D 2007 Decreased serum tryptophan concentration predicts poor prognosis in malignant melanoma patients Dermatology 214 8-14 (Pubitemid 46032994)
19. Engin A B, Ozkan Y, Fuchs D and Yardim-Akaydin S 2010 Increased tryptophan degradation in patients with bronchus carcinoma Eur. J. Cancer Care 19 803-8
20. Schroecksnadel K, Wirleitner B, Winkler C and Fuchs D 2006 Monitoring tryptophan metabolism in chronic immune activation Clin. Chim. Acta 364 82-90 (Pubitemid 43120630)
21. Weiss G, Murr C, Zoller H, Haun M, Widner B, Ludescher C and Fuchs D 1999 Modulation of neopterin formation and tryptophan degradation by Th1- and Th2-derived cytokines in human monocytic cells Clin. Exp. Immunol. 116 435-40 (Pubitemid 29258092)
22. Wirleitner B, Reider D, Ebner S, Böck G, Widner B, Jaeger M, Schennach H, Romani N and Fuchs D 2002 Monocyte-derived dendritic cells release neopterin J. Leukoc. Biol. 72 1148-53 (Pubitemid 36008885)
23. Koch A, Fohlin H and Sörenson S 2009 Prognostic significance of C-reactive protein and smoking in patients with advanced non-small cell lung cancer treated with first-line palliative chemotherapy J. Thorac. Oncol. 4 326-32
24. Pine S R, Mechanic L E, Enewold L, Chaturvedi A K, Katki H A, Zheng Y L, Bowman E D, Engels E A, Caporaso N E and Harris C C 2011 Increased levels of circulating interleukin 6, interleukin 8, C-reactive protein, and risk of lung cancer J. Natl Cancer Inst. 103 1112-22
25. Murr C, Widner B, Wirleitner B and Fuchs D 2002 Neopterin as a marker for immune system activation Curr. Drug Metab. 3 175-87 (Pubitemid 34326529)
26. Clyne B and Olshaker J S 1999 The C-reactive protein J. Emerg. Med. 17 1019-25 (Pubitemid 29528076)
27. Widner B, Werner E R, Schennach H, Wachter H and Fuchs D 1997 Simultaneous measurement of serum tryptophan and kynurenine by HPLC Clin. Chem. 43 2424-6 (Pubitemid 28022985)
28. Nathan C F, Murray H W, Wiebe M E and Rubin B Y 1983 Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity J. Exp. Med. 158 670-89 (Pubitemid 13051337)
29. Gutteridge J M and Halliwell B 2000 Free radicals and antioxidants in the year 2000. A historical look to the future Ann. New York Acad. Sci. 899 136-47 (Pubitemid 30352782)
30. Tiwari R and Pathak K 2011 Statins therapy: a review on conventional and novel formulation approaches J. Pharm. Pharmacol. 63 983-98
31. Murr C, Schroecksnadel K, Winklhofer-Roob B M, Mangge H, Böhm B O, Winkelmann B R, Maerz W and Fuchs D 2009 Inverse association between serum concentrations of neopterin and antioxidants in patients with and without angiographic coronary artery disease Atherosclerosis 202 543-9
32. Hronek M, Zadak Z, Solichova D, Jandik P and Melichar B 2000 The association between specific nutritional antioxidants and manifestation of colorectal cancer Nutrition 16 189-91 (Pubitemid 30114271)
33. Razumovitch J A, Semenkova G N, Fuchs D and Cherenkevich S N 2003 Influence of neopterin on the generation of reactive oxygen species in human neutrophils FEBS Lett. 549 83-6 (Pubitemid 36959849)
34. Razumovitch J, Fuchs D, Semenkova G N and Cherenkevich S N 2004 Influence of neopterin on generation of reactive species by myeloperoxidase in human neutrophils Biochim. Biophys. Acta 1672 46-50 (Pubitemid 38410967)
35. Murr C, Fuith L C, Widner B, Wirleitner B, Baier-Bitterlich G and Fuchs D 1999 Increased neopterin concentrations in patients with cancer: indicator of oxidative stress? Anticancer Res. 19 1721-8 (Pubitemid 29392728)
36. Mashir A, Paschke K M, van Duin D, Shrestha D K, Laskowski D, Storer M K, Yen-Lieberman B, Gordon S M, Aytekin M and Dweik R A 2011 Effect of the influenza A (H1N1) live attenuated intranasal vaccine on nitric oxide (FENO) and other volatiles in exhaled breath J. Breath Res. 5 037107
37. Zangerle R, Sarcletti M, Gallati H, Reibnegger G, Wachter H and Fuchs D 1994 Decreased plasma concentrations of HDL cholesterol in HIV-infected individuals are associated with immune activation J. Acquir. Immune Defic. Syndr. 7 1149-56
38. Nilsson-Ehle I and Nilsson-Ehle P 1990 Changes in plasma lipoproteins in acute malaria J. Int. Med. 227 151-5 (Pubitemid 20075937)
39. Kittl E M, Diridl G, Lenhart V, Neuwald C, Tomasits J, Pichler H and Bauer K 1992 HDL cholesterol as a sensitive diagnostic parameter in malaria Wien. Klin. Wochenschr. 104 21-4
40. Reibnegger G, Boonpucknavig V, Fuchs D, Hausen A, Schmutzhard E and Wachter H 1984 Urinary neopterin is elevated in patients with malaria Trans. R. Soc. Trop. Med. Hyg. 78 545-6
41. Brown A E, Webster H K, Teja-Isavadharm P and Keeratithakul D 1990 Macrophage activation in falciparum malaria as measured by neopterin and interferon-gamma Clin. Exp. Immunol. 82 97-101 (Pubitemid 20329245)
42. Chao F C, Efron B and Wolf P 1975 The possible prognostic usefulness of assessing serum proteins and cholesterol in malignancy Cancer 35 1223-9
43. Winawer S J, Flehinger B J, Buchalter J, Herbert E and Shike M 1990 Declining serum cholesterol levels prior to diagnosis of colon cancer. A time-trend, case-control study J. Am. Med. Assoc. 263 2083-5 (Pubitemid 20139957)
44. Zureik M, Courbon D and Ducimetière P 1997 Decline in serum total cholesterol and the risk of death from cancer Epidemiology 8 137-43 (Pubitemid 27084183)
45. van Duijnhoven F J et al 2011 Blood lipid and lipoprotein concentrations and colorectal cancer risk in the European Prospective Investigation Into Cancer and Nutrition Gut. 60 1094-102
46. Sok M, Ravnik J and Ravnik M 2009 Preoperative total serum cholesterol as a prognostic factor for survival in patients with resectable non-small-cell lung cancer Wien. Klin. Wochenschr. 121 314-7
47. Swaminathan N, Venkataraman K, Gadgil U and Margolin K 1993 Possible mechanism of interleukin-2-induced decline of serum cholesterol during adoptive cellular immunotherapy in cancer patients Biochem. Med. Metab. Biol. 49 212-6 (Pubitemid 23197793)
48. Weiss G 2002 Pathogenesis and treatment of anaemia of chronic disease Blood Rev. 16 87-96 (Pubitemid 34742225)